1. Kim YI, Kim SE, Jang HC, Jung SI, Song SK, Park KH. Analysis of the Clinical Characteristics and Prognostic Factors of Infectious Spondylitis. Infect Chemother. 2011. 43:48–54.
Article
2. Koo KH, Lee HJ, Chang BS, Yeom JS, Park KW, Lee CK. Differential Diagnosis between Tuberculous Spondylitis and Pyogenic Spondylitis. J Korean Soc Spine Surg. 2009. 16:112–121.
Article
3. Gouliouris T, Aliyu SH, Brown NM. Spondylodiscitis: update on diagnosis and management. J Antimicrob Chemother. 2010. 65:iii11–iii24.
Article
4. Murdoch DA. Gram-positive anaerobic cocci. Clin Microbiol Rev. 1998. 11:81–120.
Article
5. Zimmerli W. Clinical practice. Vertebral osteomyelitis. N Engl J Med. 2010. 362:1022–1029.
6. Cottle L, Riordan T. Infectious spondylodiscitis. J Infect. 2008. 56:401–412.
Article
7. Minces LR, Shields RK, Sheridan K, Ho KS, Silveira FP. Peptostreptococcus infective endocarditis and bacteremia. Analysis of cases at tertiary medical center and review of the literature. Anaerobe. 2010. 16:327–330.
Article
8. Könönen E, Bryk A, Niemi P, Kanervo-Nordström A. Antimicrobial susceptibilities of peptostreptococcus anaerobius and the newly described peptostreptococcus stomatis isolated from various human sources. Antimicrob Agents Chemother. 2007. 51:2205–2207.
Article
9. Lee KY, Chong YS, Jeong SH, Xu XS, Kwon OH. Emerging Resistance of Anaerobic Bacteria to Antimicrobial Agents in South Korea. Clin Infect Dis. 1996. 23:S73–S77.
Article
10. The Korean Society of Infectious Diseases. Korean Society for Chemotherapy. The Korean Society of Clinical Microbiology. The Korean Society of Cardiology. The Korean Society for Thoracic and Cardiovascular Surgery. Clinical Guideline for the Diagnosis and Treatment of Cardiovascular Infection. Infect Chemother. 2011. 43:129–177.